Australian Super Pty LTD Johnson & Johnson Transaction History

Australian Super Pty LTD

$16.9 Billion
Q1 2024

A detailed history of Australian Super Pty LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Australian Super Pty LTD holds 9,971 shares of JNJ stock, worth $1.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,971

Previous 596,597 98.33%

Holding current value

$1.46 Million

Previous $93.5 Million 98.31%

% of portfolio

0.01%

Previous 0.57%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$155.22 - $162.74 $91.1 Million - $95.5 Million	-586,626 Reduced 98.33%	9,971 $1.58 Million
Q4 2023 Jan 16, 2024	SELL	$145.6 - $158.88 $40 Million - $43.6 Million	-274,695 Reduced 31.53%	596,597 $93.5 Million
Q3 2023 Oct 27, 2023	SELL	$155.75 - $174.48 $37 Million - $41.5 Million	-237,831 Reduced 21.44%	871,292 $136 Million
Q2 2023 Jul 28, 2023	BUY	$154.35 - $166.11 $14.5 Million - $15.6 Million	93,796 Added 9.24%	1,109,123 $184 Million
Q1 2023 Apr 21, 2023	BUY	$151.05 - $180.26 $15 Million - $17.9 Million	99,455 Added 10.86%	1,015,327 $157 Million

Q4 2022 Feb 01, 2023	SELL	$160.2 - $179.79 $4.23 Million - $4.75 Million	-26,396 Reduced 2.8%	915,872 $162 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $71.2 Million - $79.2 Million	441,432 Added 88.14%	942,268 $154 Million
Q2 2022 Jul 13, 2022	BUY	$168.19 - $186.01 $19.2 Million - $21.2 Million	113,882 Added 29.43%	500,836 $88.9 Million
Q1 2022 Apr 29, 2022	BUY	$158.14 - $179.59 $15.1 Million - $17.2 Million	95,631 Added 32.83%	386,954 $68.6 Million
Q4 2021 Jan 24, 2022	SELL	$155.93 - $173.01 $854,340 - $947,921	-5,479 Reduced 1.85%	291,323 $49.8 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $7.73 Million - $8.59 Million	47,884 Added 19.24%	296,802 $47.9 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $10.5 Million - $11.3 Million	-65,943 Reduced 20.94%	248,918 $41 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $151 Million - $169 Million	-989,616 Reduced 75.86%	314,861 $51.7 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $19.4 Million - $22.3 Million	141,721 Added 12.19%	1,304,477 $205 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $13.1 Million - $14.4 Million	93,382 Added 8.73%	1,162,756 $173 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $74.9 Million - $90.4 Million	-581,134 Reduced 35.21%	1,069,374 $150 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $28.1 Million - $39 Million	-253,228 Reduced 13.3%	1,650,508 $216 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $52.9 Million - $60.8 Million	415,214 Added 27.89%	1,903,736 $278 Million
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $8.13 Million - $9.1 Million	64,011 Added 4.49%	1,488,522 $193 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $8.43 Million - $9.27 Million	64,254 Added 4.72%	1,424,511 $198 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $48.8 Million - $54.2 Million	387,775 Added 39.87%	1,360,257 $190 Million
Q4 2018 Feb 06, 2019	BUY	$122.84 - $147.84 $80.4 Million - $96.7 Million	654,382 Added 205.72%	972,482 $125 Million
Q3 2018 Nov 09, 2018	BUY	$121.58 - $142.88 $1.47 Million - $1.73 Million	12,100 Added 3.95%	318,100 $44 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $17.3 Million - $19 Million	144,500 Added 89.47%	306,000 $37.1 Million
Q4 2017 Jan 18, 2018	SELL	$131.22 - $143.62 $2.23 Million - $2.44 Million	-17,000 Reduced 9.52%	161,500 $22.6 Million
Q3 2017 Dec 15, 2017	SELL	$129.47 - $135.38 $2.07 Million - $2.17 Million	-16,000 Reduced 8.23%	178,500 $23.2 Million
Q1 2017 Dec 15, 2017	SELL	N/A	-21,300 Reduced 9.87%	194,500 $24.2 Million
Q4 2016 Dec 15, 2017	BUY	N/A	215,800	215,800 $0

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.

Account

Australian Super Pty LTD Johnson & Johnson Transaction History